Antibiotic treatment alone for acute rhinosinusitis gives a poor response in allergic children

G L Marseglia1, C Klersy, S Barberi

  • 1Dipartimento di Scienze Pediatriche IRCCS Policlinico San Matteo, Università di Pavia, Italy. gl.marseglia@smatteo.pv.it

Insights

Antibiotics alone may not fully resolve acute rhinosinusitis (ARS) in children, particularly endoscopic signs in allergic children. Further research is needed for comprehensive ARS treatment strategies.

Area of Science:

  • Pediatrics
  • Otolaryngology
  • Allergy and Immunology

Background:

  • Acute rhinosinusitis (ARS) is a common childhood illness.
  • Allergic rhinitis can exacerbate paranasal sinus dysfunction during viral infections.

Purpose of the Study:

  • To evaluate the efficacy of antibiotic monotherapy for treating ARS in both allergic and non-allergic children.
  • To compare symptom resolution and endoscopic sign clearance between allergic and non-allergic pediatric ARS patients receiving antibiotics.

Main Methods:

  • A cohort of 97 children (4-9 years) with ARS received amoxicillin-clavulanate for 14 days.
  • Clinical symptoms and endoscopic sinus evaluations were performed pre- and post-treatment.
  • Statistical analysis included p-values, odds ratios (OR), and Kappa agreement for symptom-endoscopic sign correlation.

Main Results:

  • Significant symptom improvement (p<0.001) was observed in 84 patients, irrespective of allergic status.
  • Endoscopic signs resolved in only 49 children, with significantly fewer resolutions in allergic children (OR 14.9, p<0.001).
  • A slight to fair agreement (Kappa=0.28) was found between clinical symptoms and endoscopic findings.

Conclusions:

  • Antibiotic therapy alone is often insufficient for complete ARS resolution, especially for endoscopic signs.
  • Allergic children with ARS appear to experience more persistent endoscopic signs despite antibiotic treatment.
  • The findings suggest a need for adjunctive therapies beyond antibiotics for managing pediatric ARS, particularly in allergic individuals.

Related Concept Videos

Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Acute Pharyngitis01:30

Acute Pharyngitis

Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
Allergic Reactions02:06

Allergic Reactions

Overview
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...